scispace - formally typeset
I

Isaiah Norton

Researcher at Brigham and Women's Hospital

Publications -  52
Citations -  3650

Isaiah Norton is an academic researcher from Brigham and Women's Hospital. The author has contributed to research in topics: Tractography & Diffusion MRI. The author has an hindex of 29, co-authored 52 publications receiving 2926 citations. Previous affiliations of Isaiah Norton include Harvard University.

Papers
More filters
Journal ArticleDOI

Classifying human brain tumors by lipid imaging with mass spectrometry

TL;DR: Together, the findings offer proof of concept that intraoperative examination and classification of brain tissue by mass spectrometry can provide surgeons, pathologists, and oncologists with critical and previously unavailable information to rapidly guide surgical resections that can improve management of patients with malignant brain tumors.
Journal ArticleDOI

Ambient mass spectrometry for the intraoperative molecular diagnosis of human brain tumors

TL;DR: The work demonstrates that DESI-MS technology has the potential to identify the histology type of brain tumors and provides information on glioma grade and, most importantly, may help define tumor margins by measuring the tumor cell concentration in a specimen.
Journal ArticleDOI

Intraoperative mass spectrometry mapping of an onco-metabolite to guide brain tumor surgery

TL;DR: It is shown that a validated molecular marker—2-hydroxyglutarate generated from isocitrate dehydrogenase 1 mutant gliomas—can be rapidly detected from tumors using a form of ambient MS that does not require sample preparation, indicating that metabolite-imaging MS could transform many aspects of surgical care.
Journal ArticleDOI

Application of desorption electrospray ionization mass spectrometry imaging in breast cancer margin analysis

TL;DR: It is shown that tumor margins can be identified using the spatial distributions and varying intensities of different lipids, and an MS-based method could be developed for the rapid intraoperative detection of residual cancer tissue during breast-conserving surgery.